TFF Pharmaceuticals, Inc. (TFFP) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-17
	10-K	10-K	10-K	10-K	S-1
Revenues	0.5	0.1	0.0	13.0	0.0
Revenue growth	462.4%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0
Gross profit	0.5	0.1	0.0	13.0	0.0
Gross margin	100.0%	100.0%		100.0%
Selling, general and administrative [+]	13.8	10.6	8.0	3.2	178.6
General and administrative	13.8	10.6	8.0	3.2	178.6
Research and development	18.5	21.3	10.7	8.8
Other operating expenses				12.0
EBITDA [+]	-31.4	-31.7
EBITDA growth	-0.8%	69.4%	69.8%
EBITDA margin	-6334.9%	-35928.8%		-84.9%
Depreciation and amortization	0.4	0.1
EBIT [+]	-31.8	-31.8	-18.7	-11.0	-178.6
EBIT growth	0.0%	70.0%	69.8%
EBIT margin	-6413.2%	-36055.2%		-84.9%
Non-recurring items				1.0
Interest income	0.0	0.1	0.1	0.1
Interest income	0.0	0.1	0.1	0.1
Other income (expense), net		0.7
Pre-tax income	-31.8	-31.0	-18.6	-11.9	-178.6
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Minority interest	-31.8	-31.0	-18.6
Net income	0.0	0.0	0.0	-36.7	-178.6
Net margin	0.0%	0.0%		-282.9%

Basic EPS [+]	$0.00	$0.00	$0.00	($5.31)
Growth			-100.0%
Diluted EPS [+]	$0.00	$0.00	$0.00	($5.31)
Growth			-100.0%

Shares outstanding (basic) [+]	30.0	24.8	20.4	6.9
Growth	20.8%	21.5%	195.8%
Shares outstanding (diluted) [+]	30.0	24.8	20.4	6.9
Growth	20.8%	21.5%	195.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.